Research conducted at the Sharon Eccles Steele Center for Translational Medicine (SCTM) at the University of Utah’s John A. Moran Eye Center explains why people carrying a block of genetic...
Gregory S. Hageman, PhD, and his talented team at the John A. Moran Eye Center have developed the first therapy for age-related macular degeneration based on a better understanding of...
Marc, Distinguished Professor of Ophthalmology and the Calvin and JeNeal Hatch Presidential Chair in Ophthalmology at the University of Utah, retired this month as Distinguished Professor Emeritus after 24 years...
Vitreoretinal surgeon and retina specialist, Mary Elizabeth Hartnett, MD, published recently how new experimental research may have a role in precision medicine. In the wet form of AMD, blood vessels...
NIH-funded research provides framework for future studies of AMD biology, therapy An international study of about 43,000 people has significantly expanded the number of genetic factors known to play a...
The Johnson Foundation out of New York donated $100,000 to the Moran Eye Center to support Age-Related Macular Degeneration (AMD) research. AMD is the leading cause of worldwide blindness.
